
GRI
USDGRI Bio Inc. Common Stock
$1.680-0.080 (-4.545%)
即時價格
Healthcare
生物科技
美國
價格圖表
Loading Chart...
關鍵指標
市場指標
開盤
$1.760
最高
$1.760
最低
$1.600
交易量
0.06M
公司基本面
市值
4.2M
行業
生物科技
國家
United States
交易統計
平均交易量
1.17M
交易所
NCM
貨幣
USD
52週範圍
最低 $1.1當前 $1.680最高 $16.949
相關新聞
Analyst Upgrades
Ascendiant Capital Maintains Buy on GRI Bio, Raises Price Target to $35
Ascendiant Capital analyst Edward Woo maintains GRI Bio with a Buy and raises the price target from $34 to $35.
查看更多
GlobeNewswire
GRI Bio Reports 6-Week Interim Lung Function Data in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis ("IPF")
No decline in lung function observed at 6-week interim analysis builds upon positive safety and biomarker data Phase 2a study fully enrolled; Topline data on track for Q3 2025 Currently available treatments for IPF are
查看更多
相關股票
CCTS
Cactus Acquisition Corp. 1 Limited Ordinary Share
NASDAQ
空白支票
DSL
DoubleLine Income Solutions Fund Common Shares of Beneficial Interests
NASDAQ
信託(教育、宗教和慈善除外)
IKT
Inhibikase Therapeutics Inc.
NASDAQ
生物科技:生物製品(無診斷物質...
CVM
Cel-Sci Corporation
NASDAQ
生物科技:生物製品(無診斷物質...
CATX
Perspective Therapeutics Inc.
NASDAQ
Medical/Dental ...
保持更新
設定價格提醒,獲取AI分析更新和即時市場新聞。